A rapid point of care immunoswab assay for SARS-CoV detection.
about
Development, characterization, and application of monoclonal antibodies against severe acute respiratory syndrome coronavirus nucleocapsid proteinAntibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug.Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
P2860
A rapid point of care immunoswab assay for SARS-CoV detection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A rapid point of care immunoswab assay for SARS-CoV detection.
@en
A rapid point of care immunoswab assay for SARS-CoV detection.
@nl
type
label
A rapid point of care immunoswab assay for SARS-CoV detection.
@en
A rapid point of care immunoswab assay for SARS-CoV detection.
@nl
prefLabel
A rapid point of care immunoswab assay for SARS-CoV detection.
@en
A rapid point of care immunoswab assay for SARS-CoV detection.
@nl
P2093
P2860
P1476
A rapid point of care immunoswab assay for SARS-CoV detection.
@en
P2093
Dipankar Das
Gustavo Zayas-Zamora
Hoon H Sunwoo
Mavanur R Suresh
Pravin K Bhatnagar
Sriram Kammila
P2860
P356
10.1016/J.JVIROMET.2008.05.023
P50
P577
2008-07-11T00:00:00Z